RIGHTPHARM LTDActive

Company number 08552235Private limited companyIncorporated 2013

Key figures

£238,228-12.2%
Net assets 2024/25
-13.8%
Average annual change 2019/20–2024/25
0200 k400 k600 k800 k2019/202020/212021/222022/232023/242024/25

Like most small UK companies, RIGHTPHARM LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
02 m4 m6 m2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand250186,319110,820177,180120,206
Total assets2,626,6342,765,2892,740,6174,899,1294,822,090
Total liabilities2,109,6572,148,6282,051,1004,627,8294,583,862
Net assets / total equity516,977616,661689,517271,300238,228
Average number of employees3352224

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: RIGHTPHARM LTD

Company

RIGHTPHARM LTD is a private limited company registered with Companies House under company number 08552235. It was incorporated on 31 May 2013. Its status is active. The registered office is in North harrow (HA2). Its nature of business (SIC 2007) is dispensing chemist in specialised stores (47730).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 Mar 2025); the company files abridged accounts (unaudited). Net assets were £238,228, down 12.2% on the previous year. Cash at bank and in hand was £120,206. Total assets were £4,822,090 and total liabilities £4,583,862. The company had an average of 24 employees. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

2 persons with significant control are registered. 7 of 7 registered charges are outstanding.

Filing deadlines

The next accounts are due by 31 Dec 2026. The next confirmation statement is due by 19 Mar 2027.